Blood–Brain Barrier‐Penetrating and Lesion‐Targeting Nanoplatforms Inspired by the Pathophysiological Features for Synergistic Ischemic Stroke Therapy
Advanced Materials · 2024-05 · 36 (21)
DOI: 10.1002/adma.202312897 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 22.02.2024. Verfasst von Lu Tang und 11 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Natural Medicines, Department of Pharmaceutics, School of Pharmacy, China Pharmaceutical University, Nanjing, 210009, P. R. C…. Hauptthemen laut MEDLINE: Blood-Brain Barrier, Ischemic Stroke. Die Arbeit wurde bisher 138-mal zitiert (Crossref) und nennt 71 Literaturangaben. Gefördert von: National Nature Science Foundation of China, Six Talent Peaks Project in Jiangsu Province, 333 High-Level Talent Development Project in Jiangsu Province.
Themen: Schlaganfall
Abstract (Originalsprache)
Ischemic stroke is a dreadful vascular disorder that poses enormous threats to the public health. Due to its complicated pathophysiological features, current treatment options after ischemic stroke attack remains unsatisfactory. Insufficient drug delivery to ischemic lesions impeded by the blood–brain barrier (BBB) largely limits the therapeutic efficacy of most anti‐stroke agents. Herein, inspired by the rapid BBB penetrability of 4T1 tumor cells upon their brain metastasis and natural roles of platelet in targeting injured vasculatures, a bio‐derived nanojacket is developed by fusing 4T1 tumor cell membrane with platelet membrane, which further clothes on the surface of paeonol and polymetformin‐loaded liposome to obtain biomimetic nanoplatforms (PP@PCL) for ischemic stroke treatment. The designed PP@PCL could remarkably alleviate ischemia‐reperfusion injury by efficiently targeting ischemic lesion, preventing neuroinflammation, scavenging excess reactive oxygen species (ROS), reprogramming microglia phenotypes, and promoting angiogenesis due to the synergistic therapeutic mechanisms that anchor the pathophysiological characteristics of ischemic stroke. As a result, PP@PCL exerts desirable therapeutic efficacy in injured PC12 neuronal cells and rat model of ischemic stroke, which significantly attenuates neuronal apoptosis, reduces infarct volume, and recovers neurological functions, bringing new insights into exploiting promising treatment strategies for cerebral ischemic stroke management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Natural Medicines, Department of Pharmaceutics, School of Pharmacy, China Pharmaceutical University, Nanjing, 210009, P. R. China.
- NMPA Key Laboratory for Research and Evaluation of Cosmetics, China Pharmaceutical University, Nanjing, 210009, P. R. China.
- CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology of China, No. 11, First North Road, Zhongguancun, Beiji…
- University of Chinese Academy of Sciences, Beijing, 100049, P. R. China.
ORCID-Profile: Xing-Jie Liang
Förderung
- National Nature Science Foundation of China
- Six Talent Peaks Project in Jiangsu Province
- 333 High-Level Talent Development Project in Jiangsu Province
- Double First-Rate Construction Plan of China Pharmaceutical University
- National Natural Science Foundation of China
Zitieren
APA
Tang, L., Yin, Y., Liu, H., Zhu, M., Cao, Y., Feng, J., Fu, C., Li, Z., Shu, W., Gao, J., Liang, X. J., & Wang, W. (2024). Blood–Brain Barrier‐Penetrating and Lesion‐Targeting Nanoplatforms Inspired by the Pathophysiological Features for Synergistic Ischemic Stroke Therapy. Advanced Materials, 36(21). https://doi.org/10.1002/adma.202312897
Vancouver
Tang L, Yin Y, Liu H, Zhu M, Cao Y, Feng J, et al. Blood–Brain Barrier‐Penetrating and Lesion‐Targeting Nanoplatforms Inspired by the Pathophysiological Features for Synergistic Ischemic Stroke Therapy. Advanced Materials. 2024;36(21). doi:10.1002/adma.202312897
BibTeX
@article{Tang2024,
author = {Tang, Lu and Yin, Yue and Liu, Hening and Zhu, Mengliang and Cao, Yuqi and Feng, Jingwen and Fu, Cong and Li, Zixuan and Shu, Weijie and Gao, Jifan and Liang, Xing-Jie and Wang, Wei},
title = {Blood–Brain Barrier‐Penetrating and Lesion‐Targeting Nanoplatforms Inspired by the Pathophysiological Features for Synergistic Ischemic Stroke Therapy},
journal = {Advanced Materials},
year = {2024},
volume = {36},
number = {21},
doi = {10.1002/adma.202312897}
}
EUVIMED